• About Us
  • Services
      Medical Services
      Department Services
  • Insurance
  • Research
  • About Us
      • International Medical Services
      • Sichuan Eye Hospital
      • AIER Eye Hospital Group

      Sichuan Eye Hospital is a modernized hospital invested by AIER Eye Hospital Group, which integrates clinical medicine, scientific research and education. The International Medical Services of Sichuan Eye Hospital has excellent specialist resources and advanced medical equipment at home and abroad, and is committed to providing personalized, customized and global synchronized ophthalmic medical care and medical services for difficult and complicated eye diseases for domestic and overseas customers.



      The International Medical Services has brought together a big group of core specialists with extensive clinical experiences, including domestic and overseas PhDs, post doctors, master and doctoral supervisors, specialists receiving special allowances from the State Council, covering dozens of ophthalmology specialties such as optometry, pediatric strabismus and amblyopia, refractive surgery, cataract, glaucoma, fundus disease, ocular trauma, orbital disease and ocular tumor, lacrimal passage, oculoplastic surgery, traditional Chinese medicine ophthalmology, ocular surface and corneal disease, etc.. We provide specialist consultation and daily ward rounds by the medical directors’ team, and telemedicine services by international specialists. For difficult and complicated ocular diseases, we provide personalized treatment plans through the multidisciplinary treatment (MDT) diagnosis and treatment model led by the team of chief physicians, doctors, post doctors and medical directors.



      The International Medical Services adheres to the "all patient-centred" conception, and provides "appointment system" registration that allows patients to choose specialists and consultation time according to their needs. We provide multilingual services in Chinese, English, Japanese and Spanish, as well as examination and medical reports in English. During the whole medical process, the patient can enjoy the green channel and the separated, private and comfortable consultation rooms and examination areas which highly protects the patients’ privacy. One-on-one accompanying services and professional post-operative management services are provided to ensure patients’ exclusive care before, during and after the medical visit. Our hospital also provides personalized services such as exclusive parking areas, customized nutritious meals and worry-free hospitalization services, etc..



      The International Medical Services has established partnerships with many domestic and foreign commercial health insurance companies and health management companies to provide efficient direct billing service. It also supports multi-currency settlement methods including UnionPay, WeChat pay, Alipay, VISA, MASTERCARD, JCB, AMERICAN EXPRESS, DISCOVER, etc..



      Sichuan Eye Hospital, approved to be established on June 9, 2017, is located at No.153, Tianfu 4th Street, Chengdu City. The hospital, constructed according to the national standard of a grade 3 level A eye hospital, covers an area of 20,000 square meters and a total floor area of nearly 45,000 square meters. In the first phase, 360 million yuan was invested and 100 beds were put into service. So far, it is the largest ophthalmic hospital in west China. The hospital has an outpatient department, an inpatient department, a day surgery center, a refractive surgery center, an optometry center, an information center, an education and training center, a 3D printing laboratory, an ophthalmology research center, a telemedicine studio, a famous ophthalmologist studio and an international medical center. It is one of the AIER Eye Hospital Group's first eight regional eye medical centers put into operation.




      The hospital brings together a number of masters, PhDs, post-doctors, master and doctoral supervisors, as well as specialists with rich clinical experience. The hospital provides basic diagnosis and treatment specialties on cataract, glaucoma, strabismus and pediatric ophthalmology, refractive error, fundus disease, corneal disease, oculoplasty and orbital tumors, lacrimal duct, ocular trauma, etc. It has an ophthalmic surgery center, a clinical anesthesia department, a visual function examination and treatment area, a laboratory, a national good clinical practice institution (GCP center), and a medical imaging department etc..




      In addition, there are general ophthalmic outpatient services, ophthalmic emergency clinics,  specialists’ outpatient and famous ophthalmologist studio services. Specialized outpatient services are offered on dry eye, presbyopia, glaucoma, uveal disease, diabetic retinopathy, high myopia, genetic and congenital eye diseases.

      The hospital gives full play to its resources and advantages in ophthalmic clinical diagnosis and treatment, ophthalmic medical technology innovation, innovative drug research and development, non-profit eye health service, etc., and makes use of modern means such as cloud computing, 5G-enabled medical big data, artificial intelligence, as well as open and innovative hospital management, so as to provide eye care in a common or customized manner and develop a medical platform integrating medicine, teaching, research and production, and vigorously promote non-profit eye health services.

      Relying on AIER Eye Hospital Group's international ophthalmic medical platform, Sichuan Eye Hospital actively undertakes domestic and foreign aid training, and builds a systematic comprehensive clinical training system. At the same time, Sichuan Eye Hospital continues to introduce advanced ophthalmic diagnosis and treatment technologies from such regions as Europe, the U.S. and Southeast Asia, boosts strategic cooperation with well-known universities and scientific research units, and actively builds an international academic platform for scientific education and research.


      On the path of "GLOBAL VISION FOR YOUR VISION", Sichuan Eye Hospital will benefit the vast number of patients with eye diseases, so that everyone, no matter rich or poor, can enjoy the right to eye health!


      AIER Eye Hospital Group is China's leading ophthalmology hospital group that covers Asia, Europe, and North America with huge scale and outstanding medical capacity. It has three listed companies in China (stock code: 300015) , Europe (Spain: CBAV), and Southeast Asia (Singapore: 40T) with a total number of 720 specialized eye hospitals and centers and the annual outpatient visits in mainland China exceeded 10 million. Among those eye hospitals and centers, there are 611 in Mainland China, 7 in Hong Kong,  China, 1 in the United States, 90 in Europe, and 12 in Southeast Asia.



      AIER is committed to the parallel introduction and absorption of world-leading ophthalmic technology and management concept, with professionalism, scale and science as its strategy to advance China's ophthalmic medical care.


      Base on constant exploration and practice, also with absorbing advanced international medical management experience, AIER Eye Hospital Group has successfully established the "hierarchical chain" management model that adapts to China's market environment. Utilizing our advantages in talent, technology and management, we aim to provide the most trusted eye care to patients all over the country by offering good medical quality, superior medical service and harmonious doctors-to-patients communication.


      In 2013, AIER and Central South University jointly set up AIER School of Ophthalmology, CSU, to educate and train medical professionals with advanced degrees,which opened a new era for social capital to be involved in medical education.


      In 2014, AIER joined the Hubei University of Science and Technology to establish the AIER School of Ophthalmology & Optometry, which aims to cultivate specialized talents in Optometry.


      In 2019, AIER Clinical College of Ophthalmology, and Ophthalmic Research Institute in Wuhan University were found.


      Besides, AIER has established 7 institutes since 2011, they are AIER Ophthalmic Research Institute, AIER Optometry Research Institute, AIER Refraction Research Institute, AIER Corneal Disease Institute, AIER Glaucoma Research Institute, AIER Retina Research Institute, and AIER Cataract and Intraocular Lens Research Institute.


      Based on this, AIER continued to create a comprehensive scientific research platform. Up to now, an innovative platform integrating science, education and research. “Two Stations” refers to National Post-Doctorates R&D Workstation and Academician Expert Hunan Provincial Workstation, which was established after approval; “Two Bases” refers to Hunan International Optometry Science and Technology Cooperation Base and HOME Program work base in Hunan Province; “Three Centers” refers to Hunan Optometry Engineering Technology Research Center, Hunan Ocular Surface Disease Clinical Medicine Research Center, and Hunan Enterprise Technology Center; meanwhile various innovative platforms such as “AIER-ICT Digital Ophthalmology Joint Laboratory” were jointly established.


      At this point, AIER has bridged all three areas of medicine, education, and research, the establishment of these educational and research institutions will significantly boost our research and clinical standards.


      In the process of rapid development, AIER has gathered and cultivated a group of experienced and innovative management team and a team of ophthalmologists with excellent medical ability and rigorous academic background. As of January, 2022,AIER has more than 40,000 employees globally, including more than 9,000 ophthalmologists and optometrists. Ophthalmologists in AIER consist of a large number of Master's supervisor, Ph.D. supervisor, Ph.D. Post doctorates, scholars trained in Europe and the United States and core experts with rich clinical experience. They are a high-profile core force in the field of ophthalmology in China.


      Since its founding, AIER always committed to the mission, "Enabling everyone, whether rich or poor, has the right to eye health." With its "cross-subsidy" model, AIER provides patients with higher quality services, in the meantime dedicate itself to the social welfare and helping vulnerable groups to promote the cause of fighting blindness and national eye health.


      With the reform on China's medical health system, AIER adapts to the national medical policy and trend, launching the "Partnership Program" in the healthcare industry to focus on changing the ecological environment for ophthalmologists and maximizing the creativity and initiative of core members in 2014. This strategy is a strong motivation for expanding AIER's scale, raising benefits. AIER has always been focusing on eye care service and will establish more professional hospitals in smaller cities and counties providing high quality and multi-level eye care to more people.